1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On September 21, 2026, abrdn Global Infrastructure Income Fund commenced a rights offering to holders of record on that date, under a dealer manager agreement with UBS Securities LLC. The offer covers up to 10,545,755 new common shares, and the rights expire on October 15, 2026 unless extended, so existing shareholders must decide whether to subscribe before then.
Each common share held at the close of business on September 21, 2026 receives one right; three rights are needed to buy one new common share.
The offer covers up to 10,545,755 common shares of beneficial interest, par value $0.001 per share.
Rights expire at 5:00 p.m. Eastern time on October 15, 2026 unless extended; Equiniti Trust Company, LLC is the subscription agent and EQ Fund Solutions, LLC the information agent.
Blue Acquisition Corp. (BACC) and Blockfusion entered a Sixth Amendment to their business combination agreement on September 21, 2026. The amendment raises the maximum earnout shares for certain Blockfusion stockholders to 15,000,000 and replaces the CoreWeave warrant with a Pubco warrant, which changes how Pubco shares are counted at closing.
Maximum earnout shares increased to 15,000,000, delivered in thirds at common stock VWAPs of $13.00, $15.00 and $17.00 per share.
CoreWeave warrant for 2,786,624 Blockfusion shares is cancelled and replaced by a Pubco warrant for 2,870,813 Class A shares at $7.4643 per share.
Other terms of the business combination agreement remain in effect; closing still depends on shareholder approval and other conditions.
Brunswick Corporation said Chairman and CEO David Foulkes will retire at the end of 2026. Executive Aine Denari becomes CEO and David Everitt becomes Non-Executive Chairman, both effective January 1, 2027, which sets a defined leadership handover for shareholders. The filing also discloses retention equity awards to three senior executives, including the CFO.
David Foulkes notified the Board on September 17, 2026 of his retirement as Chairman and CEO, effective December 31, 2026
Aine Denari, 54, currently EVP and President of Navico Group and CTO, becomes CEO with a base salary of $1,150,000
David Everitt, current Lead Independent Director, becomes Non-Executive Chairman effective January 1, 2027
Retention RSU grants with grant-date values of $3,000,000 to CFO Ryan Gwillim and $1,700,000 each to John Buelow and Brenna Preisser
Generation Income Properties completed sales of its Dollar General portfolio, a Fresenius medical property and a Vacaville property in July and August 2026. It also paid $600,000 to reacquire the 7-Eleven property in Washington, D.C., ending a March 2026 transfer of that entity. Unaudited pro forma figures show lower six-month revenue but a smaller per-share loss, as the filing presents them.
Dollar General portfolio of six properties sold for $6,246,221 with net proceeds of $2,685,000, completed August 21, 2026
Fresenius property in Chicago sold for $2,800,000 with net proceeds of approximately $1,365,000, completed August 21, 2026
Vacaville property sold for $2,475,000 on July 15, 2026; Washington, D.C. entity reacquired June 16, 2026 for $600,000 in cash
Pro forma six-month 2026 loss per share of $(2.98) compared with $(3.26) historical; pro forma revenue of $3,676,321 compared with $4,294,858 historical
Vista Gold entered into an Arrangement Agreement on September 20, 2026, under which Artemis Gold would acquire all of Vista's common shares through a court-approved plan of arrangement. Vista shareholders would receive 0.0966 Artemis Gold shares for each Vista share, which the companies say implies US$2.83 per share and a 29% premium to Vista's 20-day volume-weighted average price. The deal requires Vista shareholder approval and other regulatory and court approvals, and the companies expect completion in January 2027.
Exchange ratio of 0.0966 Artemis Gold common shares per Vista Gold share, implying US$2.83 per share and a total transaction value of about US$427 million on a 100% basis
Premium of 29% to the 20-day VWAP as of September 18, 2026, and 25% to the last closing price, according to the companies
Vista must pay a termination fee of US$18,148,536 in certain circumstances, and either party may terminate if the Effective Time has not occurred by April 15, 2027
Directors and officers have signed voting support agreements, and Vista expects its proxy statement to be mailed in November 2026 with a shareholder meeting in December 2026
On September 15, 2026, Algorhythm Holdings closed its purchase of substantially all assets of Azure Energy, LLC, paying entirely in company securities valued at $23,000,000. The same day, CEO Gary Atkinson and CFO Alex Andre were terminated, Andrew Thompson became CEO, and the company issued a $4,025,000 secured note in an exchange for its Series A Preferred Stock. The common shares issued equal 19.99% of outstanding common stock, and the filing states the company is now seeking to shift its operating focus to renewable power.
Closed September 15, 2026; price of $23,000,000 paid in 4,076,312 common shares (19.99% of outstanding as of September 14, 2026) and 22,038 Series B Preferred shares
Option to buy 79.0286% of Azure S.R.L. equity for $30,000,000 within 36 months; up to 50% of exercise price payable in cash
Andrew Thompson appointed CEO effective September 15, 2026; Gary Atkinson and Alex Andre employment terminated not for cause; Atkinson also resigned from the board
Streeterville exchanged 3,500 Series A Preferred shares for a $4,025,000 Secured Pre-Paid Purchase #5 bearing 9% interest, maturing three years from September 15, 2026
Woodward plans to cease operations at its Santa Clarita, California, facility no later than December 2027 and move military flight control actuation production to its Spartanburg, South Carolina campus. The company also agreed to sell certain legacy product lines and the Santa Clarita campus, with that sale expected to close in fiscal 2027. Woodward expects cumulative pre-tax charges of $34 million to $47.5 million, mostly cash costs, which shareholders will bear as the actions are completed.
Estimated cumulative pre-tax charges of $34 million to $47.5 million, including $23 million to $29 million of employee-related costs
About 400 roles at the Santa Clarita facility are expected to be affected
Santa Clarita operations to cease no later than December 2027; Spartanburg facility expected to go online in summer 2027
Divestiture of certain product lines and the Santa Clarita campus expected to close in fiscal year 2027
Magnite appointed Brian Gephart as Chief Financial Officer effective October 1, 2026, succeeding David Day, who announced his retirement. Gephart has been the company's Chief Accounting Officer since June 2021, and the company also named Haas Sullivan as Chief Accounting Officer effective the same date. The filing describes leadership succession and compensation terms, not financial results.
Brian Gephart, age 47, becomes CFO effective October 1, 2026, succeeding retiring CFO David Day
Gephart's equity award totals $2.25 million: $1,575,000 in RSUs granted October 1, 2026 and $675,000 in PSUs expected in 2027
Haas Sullivan, age 43, becomes Chief Accounting Officer effective October 1, 2026, with an RSU grant of approximately $600,000
IB Acquisition Corp. entered into an equity purchase facility of up to $50 million and a securities purchase agreement for senior secured convertible notes, both tied to its pending business combination with GNQ Insilico. The initial PIPE closing of $16,470,588 is set to occur just before the business combination closes, with potential additional closings up to $90 million. The notes carry a 12% interest rate and a 12-month maturity, and their conversion could dilute existing shareholders.
Equity purchase facility allows the company to sell up to $50.0 million of Class A common stock to an institutional investor over up to 36 months.
Initial PIPE closing of $16,470,588 in senior secured convertible notes, with potential additional closings up to $90,000,000.
PIPE notes bear 12% annual interest, rise to an 18% default rate, mature in 12 months and convert at an initial $10.00 per share.
Company issued a $675,000 convertible commitment note to the equity facility investor.
EverCommerce said President Matthew Feierstein resigned on September 18, 2026, as president of the company and CEO of its EverPro unit, to pursue other opportunities. The filing says the resignation does not stem from any disagreement over company operations, policies or practices. The departure takes effect October 9, 2026, unless the company and Mr. Feierstein agree on a later date, and he will serve as a paid consultant afterward.
Resignation dated September 18, 2026; effective October 9, 2026, or a later mutually agreed date
Eligible for a 2026 annual target bonus, prorated for days employed in 2026, subject to continued employment and a release of claims
Vested stock option exercise period extended to 35 months after termination, or the original expiration date if earlier
Consultant on an as-needed basis through December 31, 2026, at $500 per hour
On September 21, 2026, Insulet entered into a Ninth Amendment to its Credit Agreement with Morgan Stanley Senior Funding as administrative agent. The $475 million of existing term loans were replaced with new term loans at a margin 0.25% lower, and revolving commitments rose by $250 million to $750 million, which were undrawn at closing. For shareholders, the filing points to lower borrowing costs and more available credit, though it does not state a dollar effect on earnings.
New term loans of $475 million replaced existing term loans of equal amount, issued at par.
Term SOFR loan margin on new term loans is 1.75%, 0.25% lower than the existing margin, with a 0.00% SOFR floor.
Revolving credit commitments increased by $250 million to $750 million, undrawn at closing; term SOFR margin range cut to 1.25% to 1.75%.
Axos Bank, a subsidiary of Axos Financial, completed on September 21, 2026 its previously announced purchase of individual retirement account deposits from Capital One, National Association. The bank acquired about $1.9 billion of IRA deposits and received cash for the aggregate balance, less a negotiated premium. The filing does not disclose the premium amount or the effect on earnings.
Acquired approximately $1.9 billion of IRA deposits from Capital One, National Association
Deal completed September 21, 2026 under a Purchase and Assumption Agreement dated April 22, 2026
Bank received cash for the deposit balance, less a negotiated premium; premium amount not stated in the filing
Weave Communications disclosed that early termination of the U.S. antitrust waiting period under the HSR Act was granted on September 21, 2026, for its pending acquisition by Francisco Partners-affiliated Willow Parent, LLC. This satisfies one closing condition, and the merger is expected to close in the fourth quarter of 2026, subject to stockholder approval and other customary conditions.
Early termination of HSR Act waiting period granted September 21, 2026
Merger agreement signed August 18, 2026 with Willow Parent, LLC and Willow Merger Sub, Inc., affiliates of Francisco Partners
Closing expected in the fourth quarter of 2026, subject to stockholder approval
Preliminary proxy statement was filed with the SEC on September 15, 2026; a special stockholder meeting will be announced
TOMI Environmental Solutions and Carbonium Core, Inc. agreed to terminate their June 28, 2026 merger agreement, effective September 15, 2026. The companies cited TOMI's current financial condition and strategic direction, along with new due diligence findings on Carbonium's business operations and expected financial performance. No termination fee is payable, and each party bears its own fees and expenses, so shareholders do not face a payment tied to the deal's end.
Merger agreement dated June 28, 2026 was terminated effective September 15, 2026
TOMI's Board of Directors approved the termination on September 20, 2026
No termination fee is payable by TOMI; each party bears its own fees and expenses
CEO Halden Shane said TOMI will focus on its operating results and pursue strategic partnerships
Optimum Communications said its previously issued financial statements for fiscal 2025 and the first half of 2026 should no longer be relied upon, because it failed to recognize non-cash deferred tax benefits tied to two earlier impairment charges on its cable franchise rights. The restatements are expected to reduce previously reported net losses, but the company also expects to report a material weakness in internal control over financial reporting related to income taxes.
The restatement covers the 10-K for fiscal 2025, the 10-Qs for the periods ended September 30, 2025, March 31, 2026 and June 30, 2026, and the financial statements of subsidiary CSC Holdings, LLC.
Reported net losses would decline by approximately $430 million for the three and nine months ended September 30, 2025 and the year ended December 31, 2025, and by approximately $720 million for the quarter ended March 31, 2026 and the six
Cash balances, revenues, capital expenditures, cash flows, EBITDA and loss before income taxes are not affected, according to the filing.
The Audit Committee concluded on September 16, 2026 that the affected statements should not be relied upon; the figures remain preliminary and may change.
SmartKem's board approved on September 16, 2026 a transaction retention bonus plan for its CEO, CFO and independent directors, with up to $750,000 in total payments. The bonuses are meant to keep these people in place through the closing of the previously announced Ferrox Critical Mineterals transaction and the filing of a Form S-4 registration statement.
Total retention bonuses are up to $750,000; half is payable on board approval and the balance on filing of the Form S-4.
CEO Ian Jenks is set to receive $200,000 and CFO Barbra Keck $150,000.
Four independent directors (Steven DenBaars, Melisa Denis, Klaas de Boer and Sri Peruvemba) are each set to receive $100,000.
Recipients who resign before the earlier of the Ferrox closing or June 30, 2027 must repay 100% of the amount.
Millrose Properties entered a Commitment and Acceptance on September 21, 2026, adding Flagstar Bank, N.A. as a new lender under its Revolving Credit Facility and increasing the facility's commitments by $50 million to $1.385 billion through the accordion feature. The filing is a financing amendment to an existing credit agreement, and it does not state changes to pricing or other terms.
Revolving Credit Facility commitments increased by $50 million to $1.385 billion
Flagstar Bank, N.A. added as a new lender under the Revolving Credit Facility
Commitment and Acceptance dated September 21, 2026, under Amended and Restated Credit Agreement dated March 25, 2026, as amended August 5, 2026
JPMorgan Chase Bank, N.A. serves as administrative agent
On September 21, 2026, Orion180 Insurance Group Inc. completed its initial public offering of 20,000,000 Class A common shares at $12.00 per share, raising gross proceeds of $240.0 million before underwriting discounts and commissions. The company's amended and restated certificate of formation and bylaws took effect the same day, and five new directors were elected to the board effective September 17, 2026.
Offering: 20,000,000 shares of common stock at $12.00 per share, with gross proceeds of $240.0 million before underwriting discounts and commissions
Charter: authorized capital of 400,000,000 Class A shares, 100,000,000 Class B shares and 50,000,000 undesignated preferred shares, all with $0.001 par value
Board: Kevin Bollinger, Samir Deshpande, Robert V. Deutsch, Lawrence E. McAlee and Kernan "Kip" Oberting elected effective September 17, 2026
Agreements: Registration Rights Agreement and Exchange Agreement with Kenneth Gregg, plus indemnification agreements with directors and executive officers
On September 17, 2026, Soligenix stockholders approved raising authorized common shares from 75,000,000 to 125,000,000 and gave the board up to one year to carry out a reverse stock split at a ratio between 1-for-2 and 1-for-20. Stockholders also elected five directors and chose annual advisory votes on executive compensation. Separately, the company increased its at-the-market share sale program with Rodman & Renshaw LLC by $2,500,000, which could add dilution for shareholders.
Authorized common shares rose from 75,000,000 to 125,000,000, effective September 17, 2026 on filing with Delaware.
Board may effect a reverse split of 1-for-2 to 1-for-20 within up to one year, with the ratio set at its discretion.
Five directors elected, including Christopher J. Schaber, PhD, with 2,819,961 votes for; stockholders chose annual advisory votes on executive pay.
At-the-market sales program increased by $2,500,000; about $6,234,000 had been sold under prior supplements covering up to $6,406,000.
Calisa Acquisition Corp entered a Prepaid Forward Purchase Agreement on September 15, 2026, with investment funds managed by Harraden Circle Investments, LLC, linked to its pending business combination with Goodvision AI Inc. The Purchaser may buy up to 3,000,000 Ordinary Shares from public holders at no more than the redemption price, which was about $10.31 per share based on trust assets as of August 31, 2026, and the Purchaser will not vote those shares at the shareholder meeting.
Purchaser may buy up to 3,000,000 Ordinary Shares at no more than the redemption price, about $10.31 per share based on trust cash as of August 31, 2026.
Prepayment equal to shares purchased times the redemption price is due from trust funds no later than one business day after the business combination closes.
Unsold forward purchase shares return to the company 12 months after closing; the Seller may terminate earlier by paying the applicable Reset Price.
Effective September 21, 2026, Wolverine World Wide eliminated the position of President, Active Group, and Susie Kuhn, who held that role, left the company the same day. The company said her duties have been distributed throughout the organization. The filing does not disclose any financial impact or replacement.
Position of President, Active Group eliminated effective September 21, 2026
Susie Kuhn left the company on September 21, 2026
Company states her duties have been distributed across the organization
Filing does not name a successor or give any financial figures
The European Commission granted marketing authorization for Ubeslo and Evlarco, obicetrapib-based treatments for primary hypercholesterolaemia or mixed dyslipidaemia, marking the first regulatory approval of obicetrapib worldwide. The company's partner Menarini holds European commercialization rights, and the approvals trigger milestone payments in the mid-teens of millions of euros, with up to an additional €833 million available on future milestones.
Approvals cover all EU Member States, Iceland, Liechtenstein and Norway
Ubeslo is obicetrapib 10 mg monotherapy; Evlarco is 10 mg obicetrapib plus 10 mg ezetimibe
EC requires a post-authorization efficacy study and final results from the PREVAIL cardiovascular outcomes trial
Menarini milestone payments in the mid-teens of millions of euros triggered by the authorizations
Industrial Logistics Properties Trust appointed Anthony Paula as Chief Financial Officer and Treasurer, effective October 1, 2026, replacing Tiffany R. Sy, who resigned effective September 30, 2026. A CFO change is a notable leadership transition, and the filing does not describe any change to financial results or guidance.
Anthony Paula, age 39, appointed CFO and Treasurer by the Board on September 16, 2026, effective October 1, 2026
Tiffany R. Sy resigned as CFO and Treasurer, effective September 30, 2026
Paula is a vice president at The RMR Group LLC, the company's manager, and is a certified public accountant
Paula will resign his vice president role at Diversified Healthcare Trust in connection with the appointment
Ethan Allen's Board said it has begun a formal, independent CEO succession process and has committed to naming the next CEO no later than June 30, 2027, the date Chairman, President and CEO M. Farooq Kathwari's employment agreement is scheduled to end. Kathwari will remain a non-executive Board member until the 2027 annual meeting, when he will step down. The filing reports no financial results, and the Board said the process will consider internal and external candidates.
Board committed to announcing the next CEO no later than June 30, 2027
Kathwari continues to lead management and will remain a non-executive director until the 2027 annual meeting
A nationally recognized executive search firm has been engaged to evaluate internal and external candidates
PACS Group, Inc. said Chief Legal Officer and Secretary John Mitchell retired effective September 18, 2026, and will serve as a non-employee consultant for up to 12 months. Patrick J. Murphy succeeds him as Chief Legal Officer and Secretary effective September 21, 2026. The filing describes the change as an orderly leadership transition.
Mitchell's service as Chief Legal Officer and Secretary ended September 18, 2026, under a transition agreement with the company.
Mitchell's transition terms include 12 months of base salary continuation and COBRA premium subsidies, subject to a release of claims and continued compliance with restrictive covenants.
Murphy, previously a Partner at King & Spalding, takes over as Chief Legal Officer and Secretary on September 21, 2026, after more than two decades of senior legal roles, including about 20 years at General Electric.
On September 15, 2026, Alset Inc. bought a convertible promissory note and warrants from DSS, Inc. for $500,000 under a securities purchase agreement. DSS is a related party: Alset holds about a 39.4% equity interest in it, and Chairman and CEO Chan Heng Fai chairs DSS, so the deal is subject to DSS stockholder approval before the note can be converted or the warrants exercised.
Purchase price: $500,000 for a note payable on demand, bearing 3% simple interest per annum
Note convertible into DSS common stock at $0.50 per share; warrants cover 8,000,000 DSS shares at $0.55 per share and expire on their fifth anniversary
Conversion and exercise require DSS stockholder approval
Approved by Alset's Board and Audit Committee; Chan Heng Fai and Chan Tung Moe recused from voting
Brown-Forman completed the sale of $500 million aggregate principal amount of 5.375% notes due October 15, 2031, on September 21, 2026. The company says it may use the proceeds for general corporate purposes, including dividends, stock repurchases, and repaying or repurchasing existing debt such as commercial paper. The filing adds new long-term debt to the company's obligations, with semi-annual interest payments beginning April 15, 2027.
Principal amount: $500 million of 5.375% notes due October 15, 2031
Interest payable semi-annually on April 15 and October 15, beginning April 15, 2027
Offered under a shelf registration on Form S-3 filed March 9, 2026, with U.S. Bank Trust Company as trustee
Underwriters include Barclays Capital, BofA Securities, Citigroup, J.P. Morgan and U.S. Bancorp Investments
CVRx appointed John Landry, currently CFO of Nyxoah SA, as its Chief Financial Officer, succeeding Jared Oasheim, whose resignation was previously disclosed on June 8, 2026. Landry joins on October 12, 2026, and takes the CFO role the day after the company files its Form 10-Q for the quarter ending September 30, 2026. The filing lists a $500,000 initial base salary and initial equity awards equal to 0.80% of total common shares outstanding, which matters to shareholders as a senior finance transition.
John Landry appointed CFO; joins company October 12, 2026 and assumes the role the day after the Q3 2026 Form 10-Q is filed
Initial base salary of $500,000 with a 50% target cash incentive, pro-rated for fiscal 2026
Initial equity awards of 0.80% of total common shares outstanding, split 75% stock options and 25% RSUs
Jared Oasheim, who gave notice June 8, 2026, will remain for a transition period
Travere Therapeutics said CEO Eric Dube will step down as President, CEO and board member effective December 1, 2026, and Bradley L. Campbell, former CEO of Amicus Therapeutics, will succeed him in both roles on the same date. Dube will stay on as Executive Advisor through February 15, 2027, and his employment ends February 16, 2027, unless the two sides agree to an earlier date. The change is a planned leadership transition under agreements both parties signed on September 21, 2026.
Eric Dube's CEO and board roles end December 1, 2026; Bradley L. Campbell takes both roles that day.
Dube's employment is scheduled to end February 16, 2027, and he will serve as a consultant for up to 18 months after the resignation date.
Campbell's employment agreement sets a $1,000,000 base salary, a target bonus of 85% of base salary, and approximate equity grants of $8,250,000 in stock options and $8,250,000 in restricted stock units.
Dube will not be eligible for the 2027 cash bonus program and will receive no further stock awards, though existing awards keep vesting.
Jack in the Box appointed Rachel Ruggeri, former Starbucks CFO, as an independent director effective September 17, 2026, and director Michael Murphy will retire at the 2027 annual meeting. The company also amended its cooperation agreement with GreenWood Investors, extending its term through the nomination window for the 2028 annual meeting and limiting board size to nine directors without GreenWood's consent.
Rachel Ruggeri appointed independent director effective September 17, 2026; she previously served as EVP and CFO of Starbucks Corporation
Michael Murphy will not stand for re-election and will retire from the board at the 2027 Annual Meeting of Stockholders
GreenWood amendment extends the cooperation agreement through the 2028 annual meeting nomination window and commits the company to an investor event no later than June 30, 2027
The filing does not report financial results or guidance
On September 18, 2026, GT Biopharma amended its September 14 securities purchase agreement to add a new purchaser and raise the preferred stock offering to 8,611.111 shares with an aggregate purchase price of $7,750,000. The amendment also gives purchasers rights to buy additional preferred stock for an aggregate purchase price of $31,208,054, and the company increased its designated Series M preferred shares from 41,778 to 43,287, with the shares and warrants sold under Rule 506(b) and a resale registration statement to be filed.
Preferred stock offering increased to 8,611.111 shares of Series M 10% Convertible Preferred Stock, with an aggregate stated value of $8,611,111.11 and an aggregate purchase price of $7,750,000.
Purchasers may elect additional preferred stock purchases (Greenshoe Rights) with an aggregate stated value of up to $34,675,615 for an aggregate purchase price of $31,208,054.
Certificate of Increase filed September 18, 2026 raises designated Series M preferred shares from 41,778 to 43,287.
Company agreed to file a resale registration statement within 30 days after the initial closing and after each Greenshoe closing.
OppFi Inc. disclosed that a subsidiary borrowed $75.0 million under a senior secured multi-draw term loan dated August 10, 2026, with a fixed rate of 12.50% per annum before its pending BNCCORP acquisition closes. The company said the proceeds will support growth in finance receivables and for working capital and general corporate purposes. Shareholders should note the loan carries a 1.25% original issue discount, semi-annual amortization and covenants, and that a further $25.0 million remains available through February 10, 2027.
Initial borrowing of $75.0 million on September 15, 2026; maximum commitment $100.0 million
Fixed rate of 12.50% per annum before the BNCCORP acquisition closes, rising to 13.50% after
Maturity is four years from September 15, 2026; loans require semi-annual amortization of 10% of principal
BNCCORP stockholders adopted the merger agreement at a special meeting on September 17, 2026; regulatory approvals remain pending
Turning Point Brands CEO Graham Purdy resigned for personal reasons and will also leave the board effective September 30, 2026. The board named Executive Chairman David E. Glazek as CEO effective October 1, 2026. The company reaffirmed its 2026 Modern Oral sales guidance but lowered the top of its EBITDA guidance range, which matters to shareholders because it signals a leadership transition alongside a narrower profit outlook.
Graham Purdy steps down as President and CEO and as a director effective September 30, 2026; the company says the departure is not related to any disagreement.
David E. Glazek, Executive Chairman since 2023 and a director since 2012, becomes CEO effective October 1, 2026.
2026 Modern Oral gross sales guidance of $330 million to $350 million and net sales guidance of $260 million to $270 million were reaffirmed.
Full-year 2026 EBITDA guidance was tightened to $70 million to $80 million from $70 million to $90 million.
Bridger Aerospace Group Holdings' board appointed Rebecca Gerleman as Senior Vice President, Chief Accounting Officer, effective September 18, 2026. Ms. Gerleman had been the company's Senior Director of Technical Accounting & Financial Reporting since February 1, 2026, and previously spent about twelve years at Deloitte & Touche LLP. The filing sets her base salary at $330,000 and a one-time restricted stock unit award of $108,733.
Board appointment made September 17, 2026; effective date September 18, 2026.
Base salary of $330,000 and a one-time restricted stock unit award of $108,733 under the 2023 Omnibus Incentive Plan.
Joined the company in December 2024 as Director of Technical Accounting & Financial Reporting; promoted to Senior Director February 1, 2026; about twelve years at Deloitte & Touche LLP before that.
On September 15, 2026, DSS entered into a securities purchase agreement with Alset Inc., a related party under common control of the Chairman, under which Alset lent DSS $500,000 in exchange for a convertible demand note and warrants. The note and warrants could add up to 8,000,000 shares of common stock, and their conversion or exercise requires stockholder approval, so the deal may dilute existing shareholders if approved.
Alset lent DSS $500,000, payable on demand, with simple interest at 3% per year.
The note converts at $0.50 per share, and warrants for up to 8,000,000 shares carry an exercise price of $0.55 per share.
Both the note and warrants have five-year terms, and stockholder approval is required before conversion or exercise.
The Board and Audit Committee approved the transaction; several directors also serve at Alset.
CDW LLC and CDW Finance Corporation completed the sale of $1.5 billion in senior notes in three tranches, guaranteed by parent CDW Corporation. The notes carry fixed coupons from 5.700% to 6.350% and mature between 2029 and 2033, so the company takes on new debt that must be repaid with interest.
2029 Notes: $600 million at 5.700%, maturing September 21, 2029
2032 Notes: $500 million at 6.100%, maturing January 15, 2032
2033 Notes: $400 million at 6.350%, maturing September 21, 2033
Resources Connection, Inc. (RGP) said its board appointed Trisha Jenks, currently SVP and Corporate Controller, as Chief Accounting Officer effective October 3, 2026. The filing also references the previously announced resignation of CFO Jennifer Ryu, effective October 2, 2026, with Jessica Block named interim CFO effective October 3, 2026, so the finance leadership change is significant for shareholders.
Trisha Jenks, 50, appointed Chief Accounting Officer and principal accounting officer, effective October 3, 2026
CFO Jennifer Ryu resigning effective October 2, 2026; Jessica Block named interim CFO effective October 3, 2026
Jenks' annual base salary increased to $350,000; fiscal 2027 target bonus of $150,000, guaranteed subject to continued employment
Electra Therapeutics, Inc. closed its initial public offering on September 21, 2026, selling 23,333,334 shares of common stock at $15.00 per share, for approximately $350.0 million in gross proceeds before underwriting discounts and offering expenses. The company also filed an amended and restated certificate of incorporation and adopted amended and restated bylaws effective on the closing date.
IPO: 23,333,334 shares of common stock sold at $15.00 per share
Gross proceeds of approximately $350.0 million before underwriting discounts and estimated offering expenses
Restated certificate of incorporation filed with Delaware and restated bylaws adopted, both effective September 21, 2026
Full terms are described in the final prospectus filed September 18, 2026 under Rule 424(b)
Bloomia Holdings reported fiscal 2026 results for the year ended June 30, 2026, with revenue of $48.1 million, down slightly from $48.4 million, and a net loss attributable to the company of $11.2 million, or $4.43 per diluted share, versus a $2.6 million loss, or $1.45 per share, a year earlier. The loss reflects a $13.2 million non-cash impairment charge and excess production waste that the company attributes to an industry-wide mite issue, which pushed adjusted EBITDA to a loss of $0.5 million. Total debt fell to $21.7 million, which shareholders may weigh against the weaker operating results.
Fiscal 2026 revenue was $48.1 million, compared with $48.4 million in fiscal 2025.
Net loss attributable to Bloomia Holdings was $11.2 million, or $4.43 per diluted share, compared with a $2.6 million loss, or $1.45 per share.
Adjusted EBITDA was a loss of $0.5 million, compared with $2.0 million in fiscal 2025; the company cites over $2.5 million of excess waste.
Total debt decreased to $21.7 million at June 30, 2026, from $34.1 million at June 30, 2025.
Sajal Srivastava notified TriplePoint Venture Growth BDC Corp. (TPVG) on September 15, 2026, that he will resign as a director and as President and Chief Investment Officer, effective at the close of business on December 31, 2026. Ian Schworer was appointed Chief Investment Officer effective the same date, and the board will shrink from eight members to seven. The change shifts the leadership of the fund's investment function, but the filing does not discuss any effect on financial results.
Srivastava's resignation takes effect at the close of business on December 31, 2026; he will serve in his current roles until then.
The board, on September 18, 2026, reduced its size from eight members to seven, effective December 31, 2026.
Ian Schworer, 45, was appointed Chief Investment Officer effective December 31, 2026, and has worked at TriplePoint Capital since 2014, most recently as Chief Credit Officer.
The Company will pay no cash compensation or direct benefits to Schworer, who is an employee of TriplePoint Capital.
Dave & Buster's said its Board appointed Amanda Busby as Chief Operations Officer and Derek Sample as Chief Accounting Officer, both effective August 11, 2026. The filing also covers an August 24, 2026 press release announcing further executive appointments and promotions, but it contains no financial results or guidance.
Amanda Busby appointed Chief Operations Officer on August 11, 2026, with a base salary of $450,000 and a target bonus of 70% of salary.
Derek Sample appointed Chief Accounting Officer on August 11, 2026, and designated principal accounting officer on August 25, 2026, with a base salary of $315,000.
On August 31, 2026, Busby received 72,464 restricted stock units and an option on 74,294 shares at $8.97 per share.
The August 24, 2026 press release also named Rachel Morgan Chief Legal and Administrative Officer and Corporate Secretary, and Aldo Rosales Chief Strategy and Revenue Management Officer.
Ennis reported revenue of $102.0 million for the quarter ended August 31, 2026, up 3.3% from the prior-year quarter, but diluted earnings per share fell to $0.37 from $0.51. The company tied the decline mainly to a $5.3 million favorable litigation judgment in the prior-year quarter and a $700,000 charge this quarter, and its Board raised the quarterly dividend 5.0% to $0.2625 per share.
Revenue was $102.0 million, up $3.3 million or 3.3% from $98.7 million; gross profit margin was 29.9% versus 30.5%.
Net earnings were $9.4 million, or $0.37 per diluted share, versus $13.2 million, or $0.51, a year earlier.
The quarterly dividend rises from $0.25 to $0.2625 per share, payable November 6, 2026 to holders of record on October 9, 2026.
Cash rose to $54.0 million at August 31, 2026 from $34.6 million at February 28, 2026, and the company reports no debt.
InspireMD amended some of its outstanding Series J and Series K warrants with certain holders, lowering the exercise price on the affected shares to $0.7674 and tying their expiration to the anticipated FDA approval of CGuard Prime 80 cm. The company says that if the warrants are exercised in full, they could bring in up to $11 million in gross proceeds, which it expects to help fund the product launch, while existing shareholders face the potential dilution that would follow.
Amendments cover 50% of the Series J warrant shares and all Series K warrant shares held by participating holders, with the rest of the Series J shares unchanged at $1.3827.
New termination date is 5:00 p.m. Eastern on the earlier of May 15, 2028 or 20 trading days after the company announces FDA approval of CGuard Prime 80 cm, which it expects in Q4 2026.
The press release says up to $11 million in gross proceeds if the warrants are exercised in full; no new warrants were issued.
Some participating warrant holders are members of the company's board of directors.
On September 15, 2026, Recursion amended its master agreement with Tempus AI, extending the term to six years, removing its right to terminate for convenience, and setting annual license fees at $14 million on each of the third, fourth and fifth anniversaries, with at least $4 million payable in cash. The same day, Recursion granted Tempus a non-exclusive oncology license to its TxFM Model for a $12 million fee, paid in two $6 million installments. The filing does not state the financial effect of either agreement on Recursion's results.
The Amendment, dated September 15, 2026, extends the Master Agreement term from five to six years and eliminates Recursion's right to terminate for convenience.
Annual license fees are revised to $14 million on each of the third, fourth and fifth anniversaries, replacing the prior schedule of $22 million, $32 million and $42 million.
The TxFM License Agreement, also dated September 15, 2026, grants Tempus a two-year, non-exclusive oncology license with a $12 million fee.
The Amendment reduces the aggregate number of unique de-identified data records Recursion may access.
Coursera appointed Tom Savage as Senior Vice President, Chief Legal Officer and Corporate Secretary, effective September 21, 2026, as part of a planned leadership transition. Alan Cardenas, Senior Vice President and General Counsel, is stepping down as a Section 16 officer on the same date but will remain General Counsel until the end of 2026 and is expected to then serve as an advisor.
Savage's annual base salary is $425,000, with a target bonus of 60% of base salary.
The Human Resources and Compensation Committee granted Savage a one-time new hire equity award valued at $2.45 million, in restricted stock units.
Savage's RSUs vest over three years, with 50% vesting on the first anniversary of the effective date.
Cardenas, who has been with the company for five years, stays in his General Counsel role until the end of 2026 to support the handoff.
On September 17, 2026, subsidiary Trio Petroleum Canada entered a farmout agreement with Croverro Energy Ltd. covering petroleum and natural gas rights in Alberta and Saskatchewan. Trio can earn working interests through up to seven earning programs, each intended to drill and equip two test wells, and must decide whether to join the first program after Croverro's notice due by October 1, 2026. Shareholders should note that joining a program requires Trio to pay 100% of drilling, completion and equipping costs, and the filing does not state a total cost for the full program.
Agreement dated September 17, 2026, between Trio Petroleum Canada, Corp. and Croverro Energy Ltd.
Croverro to notify Trio of the initial earning program by October 1, 2026; participation requires a $450,000 prospect fee.
For each program Trio joins, it pays 100% of costs, earns 80% of pre-earning work interests until costs are repaid, then 60%.
Croverro remains initial operator; the press release cites 14 multilateral wells, five in Alberta and nine in Saskatchewan.
Beacon Financial Corporation said its President and Chief Executive Officer, Paul A. Perrault, is retiring effective September 21, 2026, and Sean A. Gray, its Chief Operating Officer, is taking over as President and CEO and joining the boards of the Company and Beacon Bank & Trust. The filing describes a twelve-month consulting arrangement with Mr. Perrault, including a $120,000 monthly consulting fee, and the filing does not report any financial results for the period.
Paul A. Perrault retires as President and CEO and resigns from both boards effective September 21, 2026.
Sean A. Gray, age 50, becomes President and CEO and joins the boards; he previously served as Chief Operating Officer since 2025.
Mr. Perrault's consulting agreement runs for twelve months at $120,000 per month and includes payment of his 2026 annual bonus based on actual performance.
Trilogy Metals said the U.S. Army Corps of Engineers has published a Notice of Intent to prepare an Environmental Impact Statement for its flagship Arctic Project in northwestern Alaska, formally starting the National Environmental Policy Act review and a public scoping phase. The company said the schedule still targets a draft EIS in October 2027 and a Record of Decision in September 2028, which shareholders may watch as the project's main federal permitting milestones.
Notice of Intent published by the U.S. Army Corps of Engineers, announced September 21, 2026, launching public scoping
Schedule continues to target a draft EIS in October 2027 and a Record of Decision in September 2028
Clean Water Act Section 404 permit application was filed by Ambler Metals on April 20, 2026
Arctic Project is advanced by Ambler Metals LLC, a 50/50 joint venture with South32
PEDEVCO Corp. said its President and CEO J. Douglas Schick stopped serving as CEO and director on September 21, 2026, and Chief Operating Officer Reagan Tuck (R.T.) Dukes became interim President and CEO effective that day. The company says the change is not due to any disagreement, and Schick will stay on as a non-executive Senior Advisor through December 31, 2026.
Schick ceased to be President, CEO and a board member; Dukes named interim President and CEO effective September 21, 2026
Schick's separation agreement provides 2.5 times the sum of base salary and target bonus, plus a $255,000 payment in lieu of a 2026 annual bonus
Dukes, age 42, previously served as CEO of Century Natural Resources, LLC from June 2021 to October 2025
Inflection Point Acquisition Corp. VII furnished an investor presentation for its planned business combination with Elroy Air, Inc., held at an analyst day on September 21, 2026. The combination, under a Business Combination Agreement signed June 26, 2026, would make Elroy Air a wholly owned subsidiary and rename Inflection Point as Elroy Air, Inc. The filing says the 1,410-unit pipeline is conditional and not binding, and the deal still requires a registration statement, a shareholder vote and SEC review.
Business Combination Agreement dated June 26, 2026, with Elroy Air, Inc.; Inflection Point to be renamed Elroy Air, Inc. at closing
Elroy Air reports a commercial pipeline of 1,410 units, made up of 1,150 letters of intent, 160 memorandums of understanding and 100 martial purchase agreements, all subject to conditions
Presentation cites $285M+ total capital raised, including a $100M PIPE, and a $46M, multi-year U.S. Army contract
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.